n(6)-carboxymethyllysine has been researched along with nadp in 1 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 21,608 | 25 | 3,484 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Chen, X; He, JC; Striker, GE; Torreggiani, M; Vlassara, H; Zhu, L | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and nadp
| Article | Year |
|---|---|
AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.
Topics: Active Transport, Cell Nucleus; Age Factors; Animals; Cell Line; Endothelial Cells; ErbB Receptors; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADP; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphorylation; Protein Kinase C-delta; Protein Subunits; Pyruvaldehyde; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA Interference; Signal Transduction; Time Factors; Transcription Factor RelA; Transfection; Vascular Diseases | 2010 |